本総説は，日本薬学会第 131 年会シンポジウム GS01 で発表したものを中心に記述したものである． 161 YAKUGAKU ZASSHI 132(2) 161-166 (2012) (Received August 31, 2011) P-glycoprotein (P-gp), one of the important drug-eOEux pumps, is known to aŠect pharmacokinetics and pharmacodynamics of P-gp substrate drugs. We have previously reported that intestinal P-gp expression levels are transiently decreased in streptozotocin (STZ)-induced type 1 diabetic mouse model. Herein, we examined the analgesic eŠects of orally administered morphine and its pharmacokinetic properties under diabetic conditions, speciˆcally focusing on the involvement of intestinal P-gp in a type 1 diabetic mouse model. Type 1 diabetes was induced in male ddY mice by an i.p. injection of STZ (230 mg/kg). We assessed the oral morphine analgesia using the tail-‰ick test. Serum and brain morphine content were determined on a HPLC-ECD system. Intestinal P-gp expression levels were signiˆcantly decreased on day 9 after STZ administration. On the other hands, oral morphine analgesia, and serum and brain morphine content were signiˆcantly increased on day 9 after STZ administration. The decrease in the intestinal P-gp expression levels were suppressed by aminoguanidine, a speciˆc iNOS inhibitor. Interestingly, the increase in the analgesic eŠect of morphine, as well as serum and brain morphine content, was suppressed by aminoguanidine. Conversely, there was no change in the analgesic eŠect obtained with subcutaneous morphine in STZ-treated mice. In conclusions, our ndings suggest that the oral morphine analgesia is dependent on intestinal P-gp expression, and that may be one of the problems against obtaining stable pharmacological eŠects of morphine in diabetic patients. 
はじめに
At indicated periods after STZ administration, P-gp expression level was analyzed by western blot. Relative level of P-gp expression was analyzed by the ratio of P-gp/GAPDH. Mice were anesthetized on day 3, 9 and 15 after STZ administration. Control (open column): n＝6, STZ (closed column): n＝5 7,   p＜0.01 vs. Control, unpaired Student's t-test. On day 9 after STZ administration, NOS activity (A) and P-gp expression level (B) in the cytosolic (A) and crude membrane fraction (B) of ileal mucosal epithelial cells were measured. Aminoguanidine (AG) (1 mg/mL) was added to the drinking water for 9 d. n＝3 12,   p＜0.01,  p＜0.05 vs. Control (water), ## 
